Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Psychotic Disorders | 2 | 2020 | 170 | 1.110 |
Why?
|
| Opiate Substitution Treatment | 1 | 2025 | 155 | 0.810 |
Why?
|
| Breast Neoplasms | 3 | 2020 | 2253 | 0.800 |
Why?
|
| Buprenorphine | 1 | 2025 | 173 | 0.730 |
Why?
|
| Antineoplastic Agents, Hormonal | 2 | 2019 | 161 | 0.700 |
Why?
|
| Social Support | 1 | 2024 | 624 | 0.660 |
Why?
|
| Medically Underserved Area | 1 | 2020 | 89 | 0.650 |
Why?
|
| Adaptation, Psychological | 1 | 2024 | 662 | 0.620 |
Why?
|
| Medication Adherence | 2 | 2019 | 467 | 0.570 |
Why?
|
| Opioid-Related Disorders | 1 | 2025 | 515 | 0.550 |
Why?
|
| Indians, North American | 1 | 2023 | 643 | 0.530 |
Why?
|
| Bipolar Disorder | 1 | 2019 | 263 | 0.510 |
Why?
|
| Telemedicine | 1 | 2025 | 862 | 0.500 |
Why?
|
| Substance-Related Disorders | 1 | 2023 | 1083 | 0.430 |
Why?
|
| Veterans | 1 | 2025 | 1479 | 0.410 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 991 | 0.400 |
Why?
|
| Immunoglobulins, Intravenous | 3 | 2018 | 132 | 0.380 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 1692 | 0.330 |
Why?
|
| Mental Disorders | 1 | 2018 | 1077 | 0.320 |
Why?
|
| SEER Program | 2 | 2019 | 227 | 0.280 |
Why?
|
| Thromboembolism | 2 | 2018 | 119 | 0.250 |
Why?
|
| United States | 5 | 2025 | 14870 | 0.240 |
Why?
|
| Pandemics | 2 | 2024 | 1639 | 0.230 |
Why?
|
| Administrative Claims, Healthcare | 2 | 2019 | 26 | 0.190 |
Why?
|
| Cross-Sectional Studies | 2 | 2024 | 5478 | 0.190 |
Why?
|
| Aged | 5 | 2024 | 24001 | 0.190 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2025 | 679 | 0.170 |
Why?
|
| International Classification of Diseases | 2 | 2018 | 135 | 0.170 |
Why?
|
| Medicare Part D | 1 | 2019 | 25 | 0.160 |
Why?
|
| Datasets as Topic | 1 | 2019 | 121 | 0.150 |
Why?
|
| Breast | 1 | 2019 | 151 | 0.150 |
Why?
|
| Mastectomy | 1 | 2019 | 137 | 0.150 |
Why?
|
| Drug Costs | 1 | 2019 | 107 | 0.150 |
Why?
|
| Aged, 80 and over | 3 | 2019 | 7637 | 0.150 |
Why?
|
| Female | 7 | 2025 | 73465 | 0.150 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2019 | 389 | 0.140 |
Why?
|
| Mental Health | 1 | 2024 | 729 | 0.140 |
Why?
|
| Health Expenditures | 1 | 2019 | 189 | 0.140 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2018 | 63 | 0.140 |
Why?
|
| Medical Records | 1 | 2018 | 177 | 0.130 |
Why?
|
| Receptors, Estrogen | 1 | 2019 | 436 | 0.130 |
Why?
|
| Humans | 9 | 2025 | 137782 | 0.130 |
Why?
|
| Databases, Factual | 2 | 2018 | 1357 | 0.120 |
Why?
|
| Middle Aged | 4 | 2025 | 33554 | 0.120 |
Why?
|
| Comorbidity | 1 | 2019 | 1623 | 0.110 |
Why?
|
| Venous Thromboembolism | 1 | 2018 | 316 | 0.100 |
Why?
|
| Medicare | 1 | 2018 | 773 | 0.100 |
Why?
|
| Adult | 3 | 2025 | 38023 | 0.100 |
Why?
|
| Retrospective Studies | 2 | 2019 | 15682 | 0.090 |
Why?
|
| Hospitalization | 2 | 2018 | 2200 | 0.090 |
Why?
|
| Myocardial Infarction | 1 | 2018 | 1047 | 0.080 |
Why?
|
| Young Adult | 2 | 2024 | 13240 | 0.080 |
Why?
|
| Male | 4 | 2025 | 67906 | 0.080 |
Why?
|
| Cohort Studies | 1 | 2018 | 5750 | 0.070 |
Why?
|
| Predictive Value of Tests | 2 | 2018 | 2041 | 0.050 |
Why?
|
| Electronic Health Records | 2 | 2018 | 1070 | 0.040 |
Why?
|
| Pharmacovigilance | 1 | 2018 | 23 | 0.040 |
Why?
|
| Clinical Coding | 1 | 2018 | 26 | 0.040 |
Why?
|
| Venous Thrombosis | 1 | 2018 | 190 | 0.030 |
Why?
|
| Pulmonary Embolism | 1 | 2018 | 226 | 0.030 |
Why?
|
| Autoimmune Diseases | 1 | 2018 | 460 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 1478 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 3290 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2018 | 3461 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2018 | 6084 | 0.020 |
Why?
|
| Infant | 1 | 2018 | 9482 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2018 | 11105 | 0.010 |
Why?
|
| Adolescent | 1 | 2018 | 21574 | 0.010 |
Why?
|
| Child | 1 | 2018 | 21989 | 0.010 |
Why?
|